T1	Chemical 14 60	recombinant human insulin-like growth factor-I
T2	Chemical 72 97	puromycin aminonucleoside
T3	Chemical 148 163	recombinant hGH
T4	Disease 197 214	structural injury
T5	Chemical 226 251	puromycin aminonucleoside
T6	Disease 296 314	glomerular disease
T7	Chemical 347 364	recombinant human
T8	Chemical 370 375	IGF-I
T9	Disease 420 434	growth failure
T10	Disease 448 471	chronic PAN nephropathy
T11	Disease 477 491	glomerulopathy
T12	Chemical 588 595	rhIGF-I
T13	Chemical 666 673	rhIGF-I
T14	Disease 683 694	weight gain
T15	Disease 745 759	blood pressure
T16	Disease 773 786	renal disease
T17	Chemical 831 838	rhIGF-I
T18	Disease 862 885	chronic PAN nephropathy
T20	Chemical 963 965	/-
T21	Chemical 984 986	/-
T22	Chemical 992 1004	mL/min/100 g
T23	Disease 1008 1019	body weight
T24	Chemical 1087 1090	GFR
T25	Disease 1124 1146	glomerular hypertrophy
T26	Disease 1160 1188	segmental glomerulosclerosis
T27	Disease 1190 1215	tubulointerstitial injury
T28	Chemical 1235 1250	malondialdehyde
T29	Disease 1273 1288	PAN nephropathy
T30	Chemical 1308 1315	rhIGF-I
T31	Chemical 1326 1331	IGF-I
T32	Chemical 1336 1347	GH receptor
T33	Chemical 1408 1422	IGF-I receptor
T37	Chemical 1465 1472	rhIGF-I
T38	Disease 1510 1521	weight gain
T39	Disease 1523 1537	blood pressure
T41	Chemical 1552 1555	GFR
T42	Chemical 1596 1611	malondialdehyde
T44	Disease 1638 1656	tubulointerstitial
T45	Chemical 1706 1713	rhIGF-I
T46	Chemical 1755 1765	IGF-I mRNA
T47	Chemical 1814 1819	IGF-I
T48	Chemical 1823 1835	GH receptors
T49	Chemical 1876 1883	rhIGF-I
T50	Chemical 1904 1907	GFR
T51	Disease 1921 1944	chronic PAN nephropathy
T52	Chemical 1959 1963	rhGH
T54	Chemical 1982 1989	rhIGF-I
T55	Disease 1999 2022	worsen renal functional
T56	Disease 2027 2044	structural injury
